nodes	percent_of_prediction	percent_of_DWPC	metapath
Dalfampridine—KCNA3—multiple sclerosis	0.639	1	CbGaD
Dalfampridine—CYP2E1—Fingolimod—multiple sclerosis	0.00805	0.584	CbGbCtD
Dalfampridine—KCNH5—peripheral nervous system—multiple sclerosis	0.00499	0.0469	CbGeAlD
Dalfampridine—CYP2E1—Mitoxantrone—multiple sclerosis	0.00379	0.274	CbGbCtD
Dalfampridine—KCNC1—nerve—multiple sclerosis	0.00219	0.0206	CbGeAlD
Dalfampridine—CYP2E1—Dexamethasone—multiple sclerosis	0.00196	0.142	CbGbCtD
Dalfampridine—KCNV2—retina—multiple sclerosis	0.00133	0.0125	CbGeAlD
Dalfampridine—KCNA1—nerve—multiple sclerosis	0.00131	0.0123	CbGeAlD
Dalfampridine—KCNC3—brainstem—multiple sclerosis	0.00111	0.0104	CbGeAlD
Dalfampridine—KCNA10—nervous system—multiple sclerosis	0.00107	0.0101	CbGeAlD
Dalfampridine—KCNA2—brainstem—multiple sclerosis	0.00102	0.00962	CbGeAlD
Dalfampridine—KCNG2—cerebellum—multiple sclerosis	0.00101	0.00949	CbGeAlD
Dalfampridine—KCND1—brainstem—multiple sclerosis	0.000979	0.0092	CbGeAlD
Dalfampridine—KCNH4—nervous system—multiple sclerosis	0.000957	0.00899	CbGeAlD
Dalfampridine—KCNB2—nervous system—multiple sclerosis	0.000957	0.00899	CbGeAlD
Dalfampridine—KCNG4—nervous system—multiple sclerosis	0.000957	0.00899	CbGeAlD
Dalfampridine—KCNC1—brainstem—multiple sclerosis	0.00094	0.00884	CbGeAlD
Dalfampridine—Infestation—Fingolimod—multiple sclerosis	0.000939	0.0093	CcSEcCtD
Dalfampridine—KCNG4—central nervous system—multiple sclerosis	0.000921	0.00865	CbGeAlD
Dalfampridine—KCNH4—central nervous system—multiple sclerosis	0.000921	0.00865	CbGeAlD
Dalfampridine—KCNB2—central nervous system—multiple sclerosis	0.000921	0.00865	CbGeAlD
Dalfampridine—KCNQ4—retina—multiple sclerosis	0.000907	0.00853	CbGeAlD
Dalfampridine—KCNQ5—retina—multiple sclerosis	0.000883	0.00829	CbGeAlD
Dalfampridine—KCNH5—nervous system—multiple sclerosis	0.000875	0.00822	CbGeAlD
Dalfampridine—KCNH5—central nervous system—multiple sclerosis	0.000842	0.00791	CbGeAlD
Dalfampridine—Connective tissue disorder—Fingolimod—multiple sclerosis	0.000828	0.0082	CcSEcCtD
Dalfampridine—KCNH3—medulla oblongata—multiple sclerosis	0.00082	0.00771	CbGeAlD
Dalfampridine—KCNG2—brain—multiple sclerosis	0.00082	0.00771	CbGeAlD
Dalfampridine—KCNS2—nervous system—multiple sclerosis	0.000813	0.00764	CbGeAlD
Dalfampridine—KCNA6—nervous system—multiple sclerosis	0.000813	0.00764	CbGeAlD
Dalfampridine—KCNH8—medulla oblongata—multiple sclerosis	0.000794	0.00747	CbGeAlD
Dalfampridine—KCNS2—central nervous system—multiple sclerosis	0.000783	0.00736	CbGeAlD
Dalfampridine—KCNA6—central nervous system—multiple sclerosis	0.000783	0.00736	CbGeAlD
Dalfampridine—KCNV1—nervous system—multiple sclerosis	0.000765	0.00719	CbGeAlD
Dalfampridine—Angiopathy—Fingolimod—multiple sclerosis	0.000764	0.00757	CcSEcCtD
Dalfampridine—Mediastinal disorder—Fingolimod—multiple sclerosis	0.000759	0.00752	CcSEcCtD
Dalfampridine—KCNA4—medulla oblongata—multiple sclerosis	0.00075	0.00705	CbGeAlD
Dalfampridine—Mental disorder—Fingolimod—multiple sclerosis	0.000738	0.00731	CcSEcCtD
Dalfampridine—KCNV1—central nervous system—multiple sclerosis	0.000736	0.00692	CbGeAlD
Dalfampridine—KCNH3—spinal cord—multiple sclerosis	0.000731	0.00687	CbGeAlD
Dalfampridine—KCNH4—brain—multiple sclerosis	0.000731	0.00687	CbGeAlD
Dalfampridine—KCNG4—brain—multiple sclerosis	0.000731	0.00687	CbGeAlD
Dalfampridine—KCNB2—brain—multiple sclerosis	0.000731	0.00687	CbGeAlD
Dalfampridine—KCNH8—midbrain—multiple sclerosis	0.000726	0.00682	CbGeAlD
Dalfampridine—KCNV2—nervous system—multiple sclerosis	0.000725	0.00681	CbGeAlD
Dalfampridine—KCNA5—retina—multiple sclerosis	0.000723	0.0068	CbGeAlD
Dalfampridine—KCNS1—medulla oblongata—multiple sclerosis	0.000714	0.00671	CbGeAlD
Dalfampridine—Back pain—Fingolimod—multiple sclerosis	0.000709	0.00703	CcSEcCtD
Dalfampridine—KCNH8—spinal cord—multiple sclerosis	0.000708	0.00666	CbGeAlD
Dalfampridine—KCNV2—central nervous system—multiple sclerosis	0.000698	0.00656	CbGeAlD
Dalfampridine—KCNG3—nervous system—multiple sclerosis	0.000692	0.0065	CbGeAlD
Dalfampridine—KCNC2—nervous system—multiple sclerosis	0.000692	0.0065	CbGeAlD
Dalfampridine—KCNH1—nervous system—multiple sclerosis	0.000692	0.0065	CbGeAlD
Dalfampridine—KCNA4—midbrain—multiple sclerosis	0.000686	0.00644	CbGeAlD
Dalfampridine—KCNC4—medulla oblongata—multiple sclerosis	0.000683	0.00641	CbGeAlD
Dalfampridine—KCNQ2—brainstem—multiple sclerosis	0.000676	0.00635	CbGeAlD
Dalfampridine—KCNA3—spinal cord—multiple sclerosis	0.000669	0.00629	CbGeAlD
Dalfampridine—KCNH5—brain—multiple sclerosis	0.000669	0.00628	CbGeAlD
Dalfampridine—KCNC2—central nervous system—multiple sclerosis	0.000666	0.00626	CbGeAlD
Dalfampridine—KCNH1—central nervous system—multiple sclerosis	0.000666	0.00626	CbGeAlD
Dalfampridine—KCNG3—central nervous system—multiple sclerosis	0.000666	0.00626	CbGeAlD
Dalfampridine—KCNC1—medulla oblongata—multiple sclerosis	0.000656	0.00616	CbGeAlD
Dalfampridine—KCNS1—midbrain—multiple sclerosis	0.000652	0.00613	CbGeAlD
Dalfampridine—KCNA2—midbrain—multiple sclerosis	0.000652	0.00613	CbGeAlD
Dalfampridine—KCNH1—cerebellum—multiple sclerosis	0.000651	0.00612	CbGeAlD
Dalfampridine—KCND2—brainstem—multiple sclerosis	0.00064	0.00601	CbGeAlD
Dalfampridine—KCNA2—spinal cord—multiple sclerosis	0.000636	0.00598	CbGeAlD
Dalfampridine—KCNC4—midbrain—multiple sclerosis	0.000624	0.00586	CbGeAlD
Dalfampridine—KCNS2—brain—multiple sclerosis	0.000622	0.00584	CbGeAlD
Dalfampridine—KCNA6—brain—multiple sclerosis	0.000622	0.00584	CbGeAlD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Fingolimod—multiple sclerosis	0.00062	0.00614	CcSEcCtD
Dalfampridine—KCNH3—nervous system—multiple sclerosis	0.000616	0.00579	CbGeAlD
Dalfampridine—KCNG1—nervous system—multiple sclerosis	0.000616	0.00579	CbGeAlD
Dalfampridine—KCNC1—midbrain—multiple sclerosis	0.000599	0.00563	CbGeAlD
Dalfampridine—KCNH8—nervous system—multiple sclerosis	0.000597	0.00561	CbGeAlD
Dalfampridine—KCNB1—nervous system—multiple sclerosis	0.000597	0.00561	CbGeAlD
Dalfampridine—Infection—Fingolimod—multiple sclerosis	0.000595	0.00589	CcSEcCtD
Dalfampridine—KCNG1—central nervous system—multiple sclerosis	0.000593	0.00558	CbGeAlD
Dalfampridine—KCNH3—central nervous system—multiple sclerosis	0.000593	0.00558	CbGeAlD
Dalfampridine—Nervous system disorder—Fingolimod—multiple sclerosis	0.000587	0.00581	CcSEcCtD
Dalfampridine—KCNQ3—L1CAM interactions—CD24—multiple sclerosis	0.000586	0.00418	CbGpPWpGaD
Dalfampridine—KCNA3—BDNF signaling pathway—LINGO1—multiple sclerosis	0.000586	0.00418	CbGpPWpGaD
Dalfampridine—KCNC1—spinal cord—multiple sclerosis	0.000585	0.0055	CbGeAlD
Dalfampridine—KCNF1—medulla oblongata—multiple sclerosis	0.000585	0.00549	CbGeAlD
Dalfampridine—KCNV1—brain—multiple sclerosis	0.000584	0.00549	CbGeAlD
Dalfampridine—KCNQ5—midbrain—multiple sclerosis	0.000583	0.00548	CbGeAlD
Dalfampridine—Skin disorder—Fingolimod—multiple sclerosis	0.000581	0.00576	CcSEcCtD
Dalfampridine—KCNH3—cerebellum—multiple sclerosis	0.00058	0.00545	CbGeAlD
Dalfampridine—KCNG1—cerebellum—multiple sclerosis	0.00058	0.00545	CbGeAlD
Dalfampridine—KCNC3—nervous system—multiple sclerosis	0.00058	0.00545	CbGeAlD
Dalfampridine—KCNH8—central nervous system—multiple sclerosis	0.000575	0.0054	CbGeAlD
Dalfampridine—KCNB1—central nervous system—multiple sclerosis	0.000575	0.0054	CbGeAlD
Dalfampridine—KCNA4—nervous system—multiple sclerosis	0.000564	0.0053	CbGeAlD
Dalfampridine—KCNA3—nervous system—multiple sclerosis	0.000564	0.0053	CbGeAlD
Dalfampridine—KCNH8—cerebellum—multiple sclerosis	0.000562	0.00528	CbGeAlD
Dalfampridine—KCNA1—brainstem—multiple sclerosis	0.000561	0.00527	CbGeAlD
Dalfampridine—Hypotension—Fingolimod—multiple sclerosis	0.000559	0.00554	CcSEcCtD
Dalfampridine—KCNC3—central nervous system—multiple sclerosis	0.000558	0.00524	CbGeAlD
Dalfampridine—KCND3—brainstem—multiple sclerosis	0.000558	0.00524	CbGeAlD
Dalfampridine—KCNV2—brain—multiple sclerosis	0.000554	0.00521	CbGeAlD
Dalfampridine—KCNC3—cerebellum—multiple sclerosis	0.000545	0.00512	CbGeAlD
Dalfampridine—KCNA4—central nervous system—multiple sclerosis	0.000543	0.0051	CbGeAlD
Dalfampridine—KCNA3—central nervous system—multiple sclerosis	0.000543	0.0051	CbGeAlD
Dalfampridine—KCNA1—retina—multiple sclerosis	0.000541	0.00508	CbGeAlD
Dalfampridine—Paraesthesia—Fingolimod—multiple sclerosis	0.000537	0.00532	CcSEcCtD
Dalfampridine—KCNS1—nervous system—multiple sclerosis	0.000536	0.00504	CbGeAlD
Dalfampridine—KCNA2—nervous system—multiple sclerosis	0.000536	0.00504	CbGeAlD
Dalfampridine—KCNF1—midbrain—multiple sclerosis	0.000534	0.00502	CbGeAlD
Dalfampridine—Dyspnoea—Fingolimod—multiple sclerosis	0.000534	0.00529	CcSEcCtD
Dalfampridine—Infestation NOS—Cladribine—multiple sclerosis	0.000532	0.00527	CcSEcCtD
Dalfampridine—Infestation—Cladribine—multiple sclerosis	0.000532	0.00527	CcSEcCtD
Dalfampridine—KCNA4—cerebellum—multiple sclerosis	0.00053	0.00498	CbGeAlD
Dalfampridine—KCNA3—cerebellum—multiple sclerosis	0.00053	0.00498	CbGeAlD
Dalfampridine—KCNG3—brain—multiple sclerosis	0.000529	0.00497	CbGeAlD
Dalfampridine—KCNC2—brain—multiple sclerosis	0.000529	0.00497	CbGeAlD
Dalfampridine—KCNH1—brain—multiple sclerosis	0.000529	0.00497	CbGeAlD
Dalfampridine—KCNA5—medulla oblongata—multiple sclerosis	0.000523	0.00491	CbGeAlD
Dalfampridine—KCNF1—spinal cord—multiple sclerosis	0.000521	0.0049	CbGeAlD
Dalfampridine—Urinary tract infection—Cladribine—multiple sclerosis	0.000517	0.00512	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Fingolimod—multiple sclerosis	0.000517	0.00512	CcSEcCtD
Dalfampridine—KCNS1—central nervous system—multiple sclerosis	0.000516	0.00485	CbGeAlD
Dalfampridine—KCNA2—central nervous system—multiple sclerosis	0.000516	0.00485	CbGeAlD
Dalfampridine—KCND1—nervous system—multiple sclerosis	0.000513	0.00482	CbGeAlD
Dalfampridine—KCNC4—nervous system—multiple sclerosis	0.000513	0.00482	CbGeAlD
Dalfampridine—KCNS3—medulla oblongata—multiple sclerosis	0.000512	0.00481	CbGeAlD
Dalfampridine—KCNQ3—medulla oblongata—multiple sclerosis	0.000512	0.00481	CbGeAlD
Dalfampridine—KCNQ2—Potassium Channels—KCNA3—multiple sclerosis	0.00051	0.00363	CbGpPWpGaD
Dalfampridine—KCNQ3—Potassium Channels—KCNA3—multiple sclerosis	0.00051	0.00363	CbGpPWpGaD
Dalfampridine—KCNA2—cerebellum—multiple sclerosis	0.000505	0.00474	CbGeAlD
Dalfampridine—KCNH2—Voltage gated Potassium channels—KCNA3—multiple sclerosis	0.000494	0.00353	CbGpPWpGaD
Dalfampridine—KCND1—central nervous system—multiple sclerosis	0.000494	0.00464	CbGeAlD
Dalfampridine—KCNC4—central nervous system—multiple sclerosis	0.000494	0.00464	CbGeAlD
Dalfampridine—KCNC1—nervous system—multiple sclerosis	0.000493	0.00463	CbGeAlD
Dalfampridine—KCNH7—nervous system—multiple sclerosis	0.000493	0.00463	CbGeAlD
Dalfampridine—KCNV2—Neuronal System—KCNA3—multiple sclerosis	0.000484	0.00346	CbGpPWpGaD
Dalfampridine—KCNH1—Neuronal System—KCNA3—multiple sclerosis	0.000484	0.00346	CbGpPWpGaD
Dalfampridine—KCNG4—Neuronal System—KCNA3—multiple sclerosis	0.000484	0.00346	CbGpPWpGaD
Dalfampridine—KCNA2—Neuronal System—KCNA3—multiple sclerosis	0.000484	0.00346	CbGpPWpGaD
Dalfampridine—KCNV1—Neuronal System—KCNA3—multiple sclerosis	0.000484	0.00346	CbGpPWpGaD
Dalfampridine—KCNC3—Neuronal System—KCNA3—multiple sclerosis	0.000484	0.00346	CbGpPWpGaD
Dalfampridine—KCNH3—Neuronal System—KCNA3—multiple sclerosis	0.000484	0.00346	CbGpPWpGaD
Dalfampridine—KCNH5—Neuronal System—KCNA3—multiple sclerosis	0.000484	0.00346	CbGpPWpGaD
Dalfampridine—KCNA7—Neuronal System—KCNA3—multiple sclerosis	0.000484	0.00346	CbGpPWpGaD
Dalfampridine—KCND1—Neuronal System—KCNA3—multiple sclerosis	0.000484	0.00346	CbGpPWpGaD
Dalfampridine—KCNS2—Neuronal System—KCNA3—multiple sclerosis	0.000484	0.00346	CbGpPWpGaD
Dalfampridine—KCNA5—Neuronal System—KCNA3—multiple sclerosis	0.000484	0.00346	CbGpPWpGaD
Dalfampridine—KCNG1—Neuronal System—KCNA3—multiple sclerosis	0.000484	0.00346	CbGpPWpGaD
Dalfampridine—KCNH8—Neuronal System—KCNA3—multiple sclerosis	0.000484	0.00346	CbGpPWpGaD
Dalfampridine—KCNS1—Neuronal System—KCNA3—multiple sclerosis	0.000484	0.00346	CbGpPWpGaD
Dalfampridine—KCNB2—Neuronal System—KCNA3—multiple sclerosis	0.000484	0.00346	CbGpPWpGaD
Dalfampridine—KCNA6—Neuronal System—KCNA3—multiple sclerosis	0.000484	0.00346	CbGpPWpGaD
Dalfampridine—KCNA10—Neuronal System—KCNA3—multiple sclerosis	0.000484	0.00346	CbGpPWpGaD
Dalfampridine—KCNC1—Neuronal System—KCNA3—multiple sclerosis	0.000484	0.00346	CbGpPWpGaD
Dalfampridine—KCNC4—Neuronal System—KCNA3—multiple sclerosis	0.000484	0.00346	CbGpPWpGaD
Dalfampridine—KCNA4—Neuronal System—KCNA3—multiple sclerosis	0.000484	0.00346	CbGpPWpGaD
Dalfampridine—KCNG3—Neuronal System—KCNA3—multiple sclerosis	0.000484	0.00346	CbGpPWpGaD
Dalfampridine—KCNH4—Neuronal System—KCNA3—multiple sclerosis	0.000484	0.00346	CbGpPWpGaD
Dalfampridine—KCNF1—Neuronal System—KCNA3—multiple sclerosis	0.000484	0.00346	CbGpPWpGaD
Dalfampridine—KCNC4—cerebellum—multiple sclerosis	0.000483	0.00454	CbGeAlD
Dalfampridine—KCND1—cerebellum—multiple sclerosis	0.000483	0.00454	CbGeAlD
Dalfampridine—KCNQ5—nervous system—multiple sclerosis	0.000479	0.0045	CbGeAlD
Dalfampridine—KCNH7—central nervous system—multiple sclerosis	0.000474	0.00446	CbGeAlD
Dalfampridine—KCNC1—central nervous system—multiple sclerosis	0.000474	0.00446	CbGeAlD
Dalfampridine—KCNH3—brain—multiple sclerosis	0.000471	0.00443	CbGeAlD
Dalfampridine—KCNG1—brain—multiple sclerosis	0.000471	0.00443	CbGeAlD
Dalfampridine—Connective tissue disorder—Cladribine—multiple sclerosis	0.000469	0.00465	CcSEcCtD
Dalfampridine—KCNS3—midbrain—multiple sclerosis	0.000468	0.0044	CbGeAlD
Dalfampridine—KCNQ3—midbrain—multiple sclerosis	0.000468	0.0044	CbGeAlD
Dalfampridine—KCNA5—spinal cord—multiple sclerosis	0.000466	0.00438	CbGeAlD
Dalfampridine—KCNH7—cerebellum—multiple sclerosis	0.000464	0.00436	CbGeAlD
Dalfampridine—KCNQ4—cerebellum—multiple sclerosis	0.000464	0.00436	CbGeAlD
Dalfampridine—KCNC1—cerebellum—multiple sclerosis	0.000464	0.00436	CbGeAlD
Dalfampridine—KCNQ5—central nervous system—multiple sclerosis	0.000461	0.00434	CbGeAlD
Dalfampridine—KCNS3—spinal cord—multiple sclerosis	0.000457	0.00429	CbGeAlD
Dalfampridine—KCNB1—brain—multiple sclerosis	0.000456	0.00429	CbGeAlD
Dalfampridine—KCNH8—brain—multiple sclerosis	0.000456	0.00429	CbGeAlD
Dalfampridine—KCND2—medulla oblongata—multiple sclerosis	0.000446	0.00419	CbGeAlD
Dalfampridine—KCNC3—brain—multiple sclerosis	0.000443	0.00416	CbGeAlD
Dalfampridine—KCNF1—nervous system—multiple sclerosis	0.000439	0.00413	CbGeAlD
Dalfampridine—Angiopathy—Cladribine—multiple sclerosis	0.000433	0.00429	CcSEcCtD
Dalfampridine—Infestation NOS—Azathioprine—multiple sclerosis	0.000433	0.00428	CcSEcCtD
Dalfampridine—Infestation—Azathioprine—multiple sclerosis	0.000433	0.00428	CcSEcCtD
Dalfampridine—Immune system disorder—Cladribine—multiple sclerosis	0.000431	0.00427	CcSEcCtD
Dalfampridine—KCNA3—brain—multiple sclerosis	0.000431	0.00405	CbGeAlD
Dalfampridine—KCNA4—brain—multiple sclerosis	0.000431	0.00405	CbGeAlD
Dalfampridine—Mediastinal disorder—Cladribine—multiple sclerosis	0.00043	0.00426	CcSEcCtD
Dalfampridine—Asthenia—Fingolimod—multiple sclerosis	0.000429	0.00425	CcSEcCtD
Dalfampridine—KCNF1—central nervous system—multiple sclerosis	0.000423	0.00397	CbGeAlD
Dalfampridine—Mental disorder—Cladribine—multiple sclerosis	0.000418	0.00414	CcSEcCtD
Dalfampridine—KCNF1—cerebellum—multiple sclerosis	0.000413	0.00388	CbGeAlD
Dalfampridine—KCNQ4—Neuronal System—KCNA3—multiple sclerosis	0.000412	0.00294	CbGpPWpGaD
Dalfampridine—KCNQ5—Neuronal System—KCNA3—multiple sclerosis	0.000412	0.00294	CbGpPWpGaD
Dalfampridine—KCNS1—brain—multiple sclerosis	0.00041	0.00385	CbGeAlD
Dalfampridine—KCNA2—brain—multiple sclerosis	0.00041	0.00385	CbGeAlD
Dalfampridine—KCND2—midbrain—multiple sclerosis	0.000408	0.00383	CbGeAlD
Dalfampridine—Back pain—Cladribine—multiple sclerosis	0.000402	0.00398	CcSEcCtD
Dalfampridine—KCND2—spinal cord—multiple sclerosis	0.000398	0.00374	CbGeAlD
Dalfampridine—Dizziness—Fingolimod—multiple sclerosis	0.000396	0.00392	CcSEcCtD
Dalfampridine—KCNA5—nervous system—multiple sclerosis	0.000393	0.00369	CbGeAlD
Dalfampridine—KCNC4—brain—multiple sclerosis	0.000392	0.00368	CbGeAlD
Dalfampridine—KCND1—brain—multiple sclerosis	0.000392	0.00368	CbGeAlD
Dalfampridine—KCNQ3—nervous system—multiple sclerosis	0.000385	0.00361	CbGeAlD
Dalfampridine—KCNA5—central nervous system—multiple sclerosis	0.000378	0.00355	CbGeAlD
Dalfampridine—KCNQ1—medulla oblongata—multiple sclerosis	0.000377	0.00354	CbGeAlD
Dalfampridine—KCNH7—brain—multiple sclerosis	0.000377	0.00354	CbGeAlD
Dalfampridine—KCNC1—brain—multiple sclerosis	0.000377	0.00354	CbGeAlD
Dalfampridine—KCNQ4—brain—multiple sclerosis	0.000377	0.00354	CbGeAlD
Dalfampridine—Headache—Fingolimod—multiple sclerosis	0.000375	0.00371	CcSEcCtD
Dalfampridine—KCNQ3—central nervous system—multiple sclerosis	0.00037	0.00348	CbGeAlD
Dalfampridine—KCNQ5—brain—multiple sclerosis	0.000366	0.00344	CbGeAlD
Dalfampridine—KCNQ3—cerebellum—multiple sclerosis	0.000362	0.0034	CbGeAlD
Dalfampridine—KCNA1—midbrain—multiple sclerosis	0.000357	0.00336	CbGeAlD
Dalfampridine—KCND3—midbrain—multiple sclerosis	0.000356	0.00334	CbGeAlD
Dalfampridine—KCNQ2—nervous system—multiple sclerosis	0.000354	0.00333	CbGeAlD
Dalfampridine—Chest pain—Cladribine—multiple sclerosis	0.000354	0.00351	CcSEcCtD
Dalfampridine—Anxiety—Cladribine—multiple sclerosis	0.000353	0.00349	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Cladribine—multiple sclerosis	0.000352	0.00348	CcSEcCtD
Dalfampridine—KCNH6—nervous system—multiple sclerosis	0.000351	0.0033	CbGeAlD
Dalfampridine—Immune system disorder—Azathioprine—multiple sclerosis	0.000351	0.00347	CcSEcCtD
Dalfampridine—Mediastinal disorder—Azathioprine—multiple sclerosis	0.00035	0.00347	CcSEcCtD
Dalfampridine—KCNA1—spinal cord—multiple sclerosis	0.000349	0.00328	CbGeAlD
Dalfampridine—KCNC2—Neuronal System—KCNA3—multiple sclerosis	0.000345	0.00246	CbGpPWpGaD
Dalfampridine—KCNS3—Neuronal System—KCNA3—multiple sclerosis	0.000345	0.00246	CbGpPWpGaD
Dalfampridine—KCNG2—Neuronal System—KCNA3—multiple sclerosis	0.000345	0.00246	CbGpPWpGaD
Dalfampridine—Confusional state—Cladribine—multiple sclerosis	0.000342	0.00339	CcSEcCtD
Dalfampridine—KCNQ2—central nervous system—multiple sclerosis	0.000341	0.0032	CbGeAlD
Dalfampridine—Urinary tract infection—Mitoxantrone—multiple sclerosis	0.00034	0.00337	CcSEcCtD
Dalfampridine—KCNH6—central nervous system—multiple sclerosis	0.000338	0.00318	CbGeAlD
Dalfampridine—Infection—Cladribine—multiple sclerosis	0.000337	0.00334	CcSEcCtD
Dalfampridine—KCND3—Neuronal System—KCNA3—multiple sclerosis	0.000336	0.00239	CbGpPWpGaD
Dalfampridine—KCNF1—brain—multiple sclerosis	0.000336	0.00315	CbGeAlD
Dalfampridine—KCND2—nervous system—multiple sclerosis	0.000335	0.00315	CbGeAlD
Dalfampridine—KCNQ2—cerebellum—multiple sclerosis	0.000333	0.00313	CbGeAlD
Dalfampridine—Nervous system disorder—Cladribine—multiple sclerosis	0.000333	0.0033	CcSEcCtD
Dalfampridine—Skin disorder—Cladribine—multiple sclerosis	0.00033	0.00326	CcSEcCtD
Dalfampridine—KCNB1—Neuronal System—KCNA3—multiple sclerosis	0.000327	0.00233	CbGpPWpGaD
Dalfampridine—KCND2—central nervous system—multiple sclerosis	0.000323	0.00303	CbGeAlD
Dalfampridine—Hypotension—Cladribine—multiple sclerosis	0.000317	0.00314	CcSEcCtD
Dalfampridine—KCND2—cerebellum—multiple sclerosis	0.000315	0.00296	CbGeAlD
Dalfampridine—Insomnia—Cladribine—multiple sclerosis	0.000307	0.00304	CcSEcCtD
Dalfampridine—Paraesthesia—Cladribine—multiple sclerosis	0.000305	0.00302	CcSEcCtD
Dalfampridine—Dyspnoea—Cladribine—multiple sclerosis	0.000303	0.003	CcSEcCtD
Dalfampridine—KCNA5—brain—multiple sclerosis	0.0003	0.00282	CbGeAlD
Dalfampridine—KCND2—Neuronal System—KCNA3—multiple sclerosis	0.000299	0.00213	CbGpPWpGaD
Dalfampridine—KCNQ1—Neuronal System—KCNA3—multiple sclerosis	0.000299	0.00213	CbGpPWpGaD
Dalfampridine—KCNS3—brain—multiple sclerosis	0.000294	0.00276	CbGeAlD
Dalfampridine—KCNQ3—brain—multiple sclerosis	0.000294	0.00276	CbGeAlD
Dalfampridine—KCNA1—nervous system—multiple sclerosis	0.000294	0.00276	CbGeAlD
Dalfampridine—KCNH6—Neuronal System—KCNA3—multiple sclerosis	0.000294	0.00209	CbGpPWpGaD
Dalfampridine—Gastrointestinal disorder—Cladribine—multiple sclerosis	0.000293	0.0029	CcSEcCtD
Dalfampridine—KCND3—nervous system—multiple sclerosis	0.000292	0.00275	CbGeAlD
Dalfampridine—Constipation—Cladribine—multiple sclerosis	0.00029	0.00287	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—multiple sclerosis	0.000286	0.00283	CcSEcCtD
Dalfampridine—KCNA1—central nervous system—multiple sclerosis	0.000283	0.00266	CbGeAlD
Dalfampridine—KCND3—central nervous system—multiple sclerosis	0.000281	0.00264	CbGeAlD
Dalfampridine—Feeling abnormal—Cladribine—multiple sclerosis	0.00028	0.00277	CcSEcCtD
Dalfampridine—KCNB1—Calcium Regulation in the Cardiac Cell—RGS1—multiple sclerosis	0.000278	0.00199	CbGpPWpGaD
Dalfampridine—KCNA1—cerebellum—multiple sclerosis	0.000276	0.0026	CbGeAlD
Dalfampridine—KCND3—cerebellum—multiple sclerosis	0.000275	0.00258	CbGeAlD
Dalfampridine—Infection—Azathioprine—multiple sclerosis	0.000274	0.00271	CcSEcCtD
Dalfampridine—KCNQ2—brain—multiple sclerosis	0.000271	0.00254	CbGeAlD
Dalfampridine—Urticaria—Cladribine—multiple sclerosis	0.00027	0.00267	CcSEcCtD
Dalfampridine—KCNH6—brain—multiple sclerosis	0.000268	0.00252	CbGeAlD
Dalfampridine—Skin disorder—Azathioprine—multiple sclerosis	0.000268	0.00265	CcSEcCtD
Dalfampridine—KCNA1—Neuronal System—KCNA3—multiple sclerosis	0.000265	0.00189	CbGpPWpGaD
Dalfampridine—Back pain—Mitoxantrone—multiple sclerosis	0.000264	0.00262	CcSEcCtD
Dalfampridine—Infestation—Methylprednisolone—multiple sclerosis	0.000263	0.00261	CcSEcCtD
Dalfampridine—Infestation NOS—Methylprednisolone—multiple sclerosis	0.000263	0.00261	CcSEcCtD
Dalfampridine—KCNH7—Neuronal System—KCNA3—multiple sclerosis	0.000262	0.00187	CbGpPWpGaD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—C4A—multiple sclerosis	0.000261	0.00186	CbGpPWpGaD
Dalfampridine—Hypotension—Azathioprine—multiple sclerosis	0.000258	0.00255	CcSEcCtD
Dalfampridine—KCND2—brain—multiple sclerosis	0.000256	0.00241	CbGeAlD
Dalfampridine—KCNH2—Potassium Channels—KCNA3—multiple sclerosis	0.000254	0.00181	CbGpPWpGaD
Dalfampridine—Hypersensitivity—Cladribine—multiple sclerosis	0.00025	0.00248	CcSEcCtD
Dalfampridine—Asthenia—Cladribine—multiple sclerosis	0.000243	0.00241	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.000238	0.00236	CcSEcCtD
Dalfampridine—Convulsion—Mitoxantrone—multiple sclerosis	0.000237	0.00235	CcSEcCtD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—PLP1—multiple sclerosis	0.000233	0.00166	CbGpPWpGaD
Dalfampridine—Chest pain—Mitoxantrone—multiple sclerosis	0.000233	0.0023	CcSEcCtD
Dalfampridine—Connective tissue disorder—Methylprednisolone—multiple sclerosis	0.000232	0.0023	CcSEcCtD
Dalfampridine—Anxiety—Mitoxantrone—multiple sclerosis	0.000232	0.0023	CcSEcCtD
Dalfampridine—Feeling abnormal—Azathioprine—multiple sclerosis	0.000227	0.00225	CcSEcCtD
Dalfampridine—Confusional state—Mitoxantrone—multiple sclerosis	0.000225	0.00223	CcSEcCtD
Dalfampridine—KCNA1—brain—multiple sclerosis	0.000225	0.00211	CbGeAlD
Dalfampridine—Dizziness—Cladribine—multiple sclerosis	0.000224	0.00222	CcSEcCtD
Dalfampridine—KCND3—brain—multiple sclerosis	0.000223	0.0021	CbGeAlD
Dalfampridine—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.000223	0.00221	CcSEcCtD
Dalfampridine—KCNQ2—Neuronal System—KCNA3—multiple sclerosis	0.000222	0.00159	CbGpPWpGaD
Dalfampridine—KCNQ3—Neuronal System—KCNA3—multiple sclerosis	0.000222	0.00159	CbGpPWpGaD
Dalfampridine—Infection—Mitoxantrone—multiple sclerosis	0.000222	0.00219	CcSEcCtD
Dalfampridine—KCNQ2—Axon guidance—CD24—multiple sclerosis	0.000221	0.00158	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—CD24—multiple sclerosis	0.000221	0.00158	CbGpPWpGaD
Dalfampridine—Skin disorder—Mitoxantrone—multiple sclerosis	0.000217	0.00215	CcSEcCtD
Dalfampridine—KCNQ1—brain—multiple sclerosis	0.000216	0.00203	CbGeAlD
Dalfampridine—Vomiting—Cladribine—multiple sclerosis	0.000216	0.00214	CcSEcCtD
Dalfampridine—Angiopathy—Methylprednisolone—multiple sclerosis	0.000214	0.00212	CcSEcCtD
Dalfampridine—Rash—Cladribine—multiple sclerosis	0.000214	0.00212	CcSEcCtD
Dalfampridine—Dermatitis—Cladribine—multiple sclerosis	0.000214	0.00212	CcSEcCtD
Dalfampridine—Immune system disorder—Methylprednisolone—multiple sclerosis	0.000213	0.00211	CcSEcCtD
Dalfampridine—Mediastinal disorder—Methylprednisolone—multiple sclerosis	0.000213	0.00211	CcSEcCtD
Dalfampridine—Headache—Cladribine—multiple sclerosis	0.000213	0.00211	CcSEcCtD
Dalfampridine—Hypotension—Mitoxantrone—multiple sclerosis	0.000208	0.00206	CcSEcCtD
Dalfampridine—Mental disorder—Methylprednisolone—multiple sclerosis	0.000207	0.00205	CcSEcCtD
Dalfampridine—Angioedema—Prednisolone—multiple sclerosis	0.000205	0.00203	CcSEcCtD
Dalfampridine—Hypersensitivity—Azathioprine—multiple sclerosis	0.000203	0.00201	CcSEcCtD
Dalfampridine—Nausea—Cladribine—multiple sclerosis	0.000202	0.002	CcSEcCtD
Dalfampridine—Paraesthesia—Mitoxantrone—multiple sclerosis	0.0002	0.00198	CcSEcCtD
Dalfampridine—Back pain—Triamcinolone—multiple sclerosis	0.000199	0.00198	CcSEcCtD
Dalfampridine—Dyspnoea—Mitoxantrone—multiple sclerosis	0.000199	0.00197	CcSEcCtD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—AQP4—multiple sclerosis	0.000198	0.00141	CbGpPWpGaD
Dalfampridine—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000196	0.00194	CcSEcCtD
Dalfampridine—Angiopathy—Betamethasone—multiple sclerosis	0.000195	0.00193	CcSEcCtD
Dalfampridine—Angiopathy—Dexamethasone—multiple sclerosis	0.000195	0.00193	CcSEcCtD
Dalfampridine—KCNA3—BDNF signaling pathway—CNR1—multiple sclerosis	0.000195	0.00139	CbGpPWpGaD
Dalfampridine—Convulsion—Prednisolone—multiple sclerosis	0.000194	0.00192	CcSEcCtD
Dalfampridine—Constipation—Mitoxantrone—multiple sclerosis	0.000191	0.00189	CcSEcCtD
Dalfampridine—Angioedema—Triamcinolone—multiple sclerosis	0.000188	0.00187	CcSEcCtD
Dalfampridine—Angioedema—Methylprednisolone—multiple sclerosis	0.000188	0.00186	CcSEcCtD
Dalfampridine—Connective tissue disorder—Prednisone—multiple sclerosis	0.000184	0.00182	CcSEcCtD
Dalfampridine—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000184	0.00182	CcSEcCtD
Dalfampridine—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000183	0.00181	CcSEcCtD
Dalfampridine—Dizziness—Azathioprine—multiple sclerosis	0.000182	0.00181	CcSEcCtD
Dalfampridine—Convulsion—Triamcinolone—multiple sclerosis	0.000179	0.00177	CcSEcCtD
Dalfampridine—Convulsion—Methylprednisolone—multiple sclerosis	0.000178	0.00177	CcSEcCtD
Dalfampridine—Urticaria—Mitoxantrone—multiple sclerosis	0.000177	0.00175	CcSEcCtD
Dalfampridine—Vomiting—Azathioprine—multiple sclerosis	0.000175	0.00174	CcSEcCtD
Dalfampridine—Anxiety—Methylprednisolone—multiple sclerosis	0.000175	0.00173	CcSEcCtD
Dalfampridine—Infestation NOS—Methotrexate—multiple sclerosis	0.000174	0.00173	CcSEcCtD
Dalfampridine—Infestation—Methotrexate—multiple sclerosis	0.000174	0.00173	CcSEcCtD
Dalfampridine—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000174	0.00124	CbGpPWpGaD
Dalfampridine—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000174	0.00124	CbGpPWpGaD
Dalfampridine—Rash—Azathioprine—multiple sclerosis	0.000174	0.00172	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000174	0.00172	CcSEcCtD
Dalfampridine—Dermatitis—Azathioprine—multiple sclerosis	0.000174	0.00172	CcSEcCtD
Dalfampridine—Headache—Azathioprine—multiple sclerosis	0.000173	0.00171	CcSEcCtD
Dalfampridine—Angioedema—Betamethasone—multiple sclerosis	0.000171	0.00169	CcSEcCtD
Dalfampridine—Angioedema—Dexamethasone—multiple sclerosis	0.000171	0.00169	CcSEcCtD
Dalfampridine—Angiopathy—Prednisone—multiple sclerosis	0.00017	0.00168	CcSEcCtD
Dalfampridine—Confusional state—Methylprednisolone—multiple sclerosis	0.000169	0.00168	CcSEcCtD
Dalfampridine—Immune system disorder—Prednisone—multiple sclerosis	0.000169	0.00167	CcSEcCtD
Dalfampridine—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000168	0.00167	CcSEcCtD
Dalfampridine—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000168	0.00166	CcSEcCtD
Dalfampridine—Infection—Triamcinolone—multiple sclerosis	0.000167	0.00166	CcSEcCtD
Dalfampridine—Infection—Methylprednisolone—multiple sclerosis	0.000167	0.00165	CcSEcCtD
Dalfampridine—Insomnia—Prednisolone—multiple sclerosis	0.000165	0.00164	CcSEcCtD
Dalfampridine—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000165	0.00163	CcSEcCtD
Dalfampridine—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000164	0.00163	CcSEcCtD
Dalfampridine—Paraesthesia—Prednisolone—multiple sclerosis	0.000164	0.00163	CcSEcCtD
Dalfampridine—Mental disorder—Prednisone—multiple sclerosis	0.000164	0.00162	CcSEcCtD
Dalfampridine—Nausea—Azathioprine—multiple sclerosis	0.000164	0.00162	CcSEcCtD
Dalfampridine—Skin disorder—Methylprednisolone—multiple sclerosis	0.000163	0.00162	CcSEcCtD
Dalfampridine—Convulsion—Dexamethasone—multiple sclerosis	0.000162	0.00161	CcSEcCtD
Dalfampridine—Convulsion—Betamethasone—multiple sclerosis	0.000162	0.00161	CcSEcCtD
Dalfampridine—Asthenia—Mitoxantrone—multiple sclerosis	0.00016	0.00158	CcSEcCtD
Dalfampridine—Anxiety—Dexamethasone—multiple sclerosis	0.000159	0.00157	CcSEcCtD
Dalfampridine—Anxiety—Betamethasone—multiple sclerosis	0.000159	0.00157	CcSEcCtD
Dalfampridine—KCNQ2—Developmental Biology—CD24—multiple sclerosis	0.000158	0.00113	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—CD24—multiple sclerosis	0.000158	0.00113	CbGpPWpGaD
Dalfampridine—KCNA3—BDNF signaling pathway—BDNF—multiple sclerosis	0.000157	0.00112	CbGpPWpGaD
Dalfampridine—Hypotension—Methylprednisolone—multiple sclerosis	0.000157	0.00155	CcSEcCtD
Dalfampridine—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000153	0.00151	CcSEcCtD
Dalfampridine—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000153	0.00151	CcSEcCtD
Dalfampridine—Insomnia—Triamcinolone—multiple sclerosis	0.000152	0.00151	CcSEcCtD
Dalfampridine—Insomnia—Methylprednisolone—multiple sclerosis	0.000152	0.0015	CcSEcCtD
Dalfampridine—Infection—Dexamethasone—multiple sclerosis	0.000152	0.0015	CcSEcCtD
Dalfampridine—Infection—Betamethasone—multiple sclerosis	0.000152	0.0015	CcSEcCtD
Dalfampridine—Paraesthesia—Triamcinolone—multiple sclerosis	0.000151	0.0015	CcSEcCtD
Dalfampridine—Feeling abnormal—Prednisolone—multiple sclerosis	0.000151	0.00149	CcSEcCtD
Dalfampridine—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000151	0.00149	CcSEcCtD
Dalfampridine—Dyspnoea—Triamcinolone—multiple sclerosis	0.00015	0.00149	CcSEcCtD
Dalfampridine—Nervous system disorder—Dexamethasone—multiple sclerosis	0.00015	0.00148	CcSEcCtD
Dalfampridine—Nervous system disorder—Betamethasone—multiple sclerosis	0.00015	0.00148	CcSEcCtD
Dalfampridine—Angioedema—Prednisone—multiple sclerosis	0.000149	0.00147	CcSEcCtD
Dalfampridine—Dyspepsia—Triamcinolone—multiple sclerosis	0.000148	0.00147	CcSEcCtD
Dalfampridine—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000148	0.00146	CcSEcCtD
Dalfampridine—Urticaria—Prednisolone—multiple sclerosis	0.000145	0.00144	CcSEcCtD
Dalfampridine—KCNH2—medulla oblongata—multiple sclerosis	0.000144	0.00135	CbGeAlD
Dalfampridine—Hypotension—Betamethasone—multiple sclerosis	0.000143	0.00141	CcSEcCtD
Dalfampridine—Hypotension—Dexamethasone—multiple sclerosis	0.000143	0.00141	CcSEcCtD
Dalfampridine—Angiopathy—Methotrexate—multiple sclerosis	0.000142	0.00141	CcSEcCtD
Dalfampridine—Vomiting—Mitoxantrone—multiple sclerosis	0.000142	0.0014	CcSEcCtD
Dalfampridine—Immune system disorder—Methotrexate—multiple sclerosis	0.000141	0.0014	CcSEcCtD
Dalfampridine—Convulsion—Prednisone—multiple sclerosis	0.000141	0.0014	CcSEcCtD
Dalfampridine—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000141	0.0014	CcSEcCtD
Dalfampridine—Rash—Mitoxantrone—multiple sclerosis	0.000141	0.00139	CcSEcCtD
Dalfampridine—Dermatitis—Mitoxantrone—multiple sclerosis	0.00014	0.00139	CcSEcCtD
Dalfampridine—KCNA3—BDNF signaling pathway—SPP1—multiple sclerosis	0.00014	0.000997	CbGpPWpGaD
Dalfampridine—Headache—Mitoxantrone—multiple sclerosis	0.00014	0.00138	CcSEcCtD
Dalfampridine—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000139	0.00137	CcSEcCtD
Dalfampridine—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000138	0.00137	CcSEcCtD
Dalfampridine—Anxiety—Prednisone—multiple sclerosis	0.000138	0.00137	CcSEcCtD
Dalfampridine—Insomnia—Dexamethasone—multiple sclerosis	0.000138	0.00137	CcSEcCtD
Dalfampridine—Insomnia—Betamethasone—multiple sclerosis	0.000138	0.00137	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000138	0.00136	CcSEcCtD
Dalfampridine—Paraesthesia—Dexamethasone—multiple sclerosis	0.000137	0.00136	CcSEcCtD
Dalfampridine—Paraesthesia—Betamethasone—multiple sclerosis	0.000137	0.00136	CcSEcCtD
Dalfampridine—Mental disorder—Methotrexate—multiple sclerosis	0.000137	0.00136	CcSEcCtD
Dalfampridine—KCNH8—Neuronal System—BCHE—multiple sclerosis	0.000136	0.000969	CbGpPWpGaD
Dalfampridine—KCNA6—Neuronal System—BCHE—multiple sclerosis	0.000136	0.000969	CbGpPWpGaD
Dalfampridine—KCNG1—Neuronal System—BCHE—multiple sclerosis	0.000136	0.000969	CbGpPWpGaD
Dalfampridine—KCNG3—Neuronal System—BCHE—multiple sclerosis	0.000136	0.000969	CbGpPWpGaD
Dalfampridine—KCND1—Neuronal System—BCHE—multiple sclerosis	0.000136	0.000969	CbGpPWpGaD
Dalfampridine—KCNS1—Neuronal System—BCHE—multiple sclerosis	0.000136	0.000969	CbGpPWpGaD
Dalfampridine—KCNA4—Neuronal System—BCHE—multiple sclerosis	0.000136	0.000969	CbGpPWpGaD
Dalfampridine—KCNA10—Neuronal System—BCHE—multiple sclerosis	0.000136	0.000969	CbGpPWpGaD
Dalfampridine—KCNA5—Neuronal System—BCHE—multiple sclerosis	0.000136	0.000969	CbGpPWpGaD
Dalfampridine—KCNV1—Neuronal System—BCHE—multiple sclerosis	0.000136	0.000969	CbGpPWpGaD
Dalfampridine—KCNC4—Neuronal System—BCHE—multiple sclerosis	0.000136	0.000969	CbGpPWpGaD
Dalfampridine—KCNH4—Neuronal System—BCHE—multiple sclerosis	0.000136	0.000969	CbGpPWpGaD
Dalfampridine—KCNH5—Neuronal System—BCHE—multiple sclerosis	0.000136	0.000969	CbGpPWpGaD
Dalfampridine—KCNF1—Neuronal System—BCHE—multiple sclerosis	0.000136	0.000969	CbGpPWpGaD
Dalfampridine—KCNC1—Neuronal System—BCHE—multiple sclerosis	0.000136	0.000969	CbGpPWpGaD
Dalfampridine—KCNC3—Neuronal System—BCHE—multiple sclerosis	0.000136	0.000969	CbGpPWpGaD
Dalfampridine—KCNA2—Neuronal System—BCHE—multiple sclerosis	0.000136	0.000969	CbGpPWpGaD
Dalfampridine—KCNB2—Neuronal System—BCHE—multiple sclerosis	0.000136	0.000969	CbGpPWpGaD
Dalfampridine—KCNH3—Neuronal System—BCHE—multiple sclerosis	0.000136	0.000969	CbGpPWpGaD
Dalfampridine—KCNG4—Neuronal System—BCHE—multiple sclerosis	0.000136	0.000969	CbGpPWpGaD
Dalfampridine—KCNV2—Neuronal System—BCHE—multiple sclerosis	0.000136	0.000969	CbGpPWpGaD
Dalfampridine—KCNA7—Neuronal System—BCHE—multiple sclerosis	0.000136	0.000969	CbGpPWpGaD
Dalfampridine—KCNS2—Neuronal System—BCHE—multiple sclerosis	0.000136	0.000969	CbGpPWpGaD
Dalfampridine—KCNH1—Neuronal System—BCHE—multiple sclerosis	0.000136	0.000969	CbGpPWpGaD
Dalfampridine—Hypersensitivity—Prednisolone—multiple sclerosis	0.000135	0.00134	CcSEcCtD
Dalfampridine—Dyspepsia—Dexamethasone—multiple sclerosis	0.000134	0.00133	CcSEcCtD
Dalfampridine—Dyspepsia—Betamethasone—multiple sclerosis	0.000134	0.00133	CcSEcCtD
Dalfampridine—Urticaria—Triamcinolone—multiple sclerosis	0.000134	0.00132	CcSEcCtD
Dalfampridine—Urticaria—Methylprednisolone—multiple sclerosis	0.000133	0.00132	CcSEcCtD
Dalfampridine—Anaphylactic shock—Prednisone—multiple sclerosis	0.000133	0.00132	CcSEcCtD
Dalfampridine—Nausea—Mitoxantrone—multiple sclerosis	0.000132	0.00131	CcSEcCtD
Dalfampridine—Infection—Prednisone—multiple sclerosis	0.000132	0.00131	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000132	0.00131	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000132	0.00131	CcSEcCtD
Dalfampridine—Back pain—Methotrexate—multiple sclerosis	0.000132	0.0013	CcSEcCtD
Dalfampridine—KCNH2—midbrain—multiple sclerosis	0.000131	0.00123	CbGeAlD
Dalfampridine—Nervous system disorder—Prednisone—multiple sclerosis	0.00013	0.00129	CcSEcCtD
Dalfampridine—Skin disorder—Prednisone—multiple sclerosis	0.000129	0.00128	CcSEcCtD
Dalfampridine—KCNH2—spinal cord—multiple sclerosis	0.000128	0.0012	CbGeAlD
Dalfampridine—Feeling abnormal—Betamethasone—multiple sclerosis	0.000126	0.00125	CcSEcCtD
Dalfampridine—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000126	0.00125	CcSEcCtD
Dalfampridine—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000124	0.00123	CcSEcCtD
Dalfampridine—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000124	0.00123	CcSEcCtD
Dalfampridine—Urticaria—Betamethasone—multiple sclerosis	0.000121	0.0012	CcSEcCtD
Dalfampridine—Urticaria—Dexamethasone—multiple sclerosis	0.000121	0.0012	CcSEcCtD
Dalfampridine—KCNA3—Neuronal System—BCHE—multiple sclerosis	0.000121	0.000864	CbGpPWpGaD
Dalfampridine—Dizziness—Prednisolone—multiple sclerosis	0.000121	0.0012	CcSEcCtD
Dalfampridine—Asthenia—Triamcinolone—multiple sclerosis	0.000121	0.0012	CcSEcCtD
Dalfampridine—Asthenia—Methylprednisolone—multiple sclerosis	0.00012	0.00119	CcSEcCtD
Dalfampridine—Insomnia—Prednisone—multiple sclerosis	0.00012	0.00119	CcSEcCtD
Dalfampridine—Paraesthesia—Prednisone—multiple sclerosis	0.000119	0.00118	CcSEcCtD
Dalfampridine—Convulsion—Methotrexate—multiple sclerosis	0.000118	0.00117	CcSEcCtD
Dalfampridine—Dyspepsia—Prednisone—multiple sclerosis	0.000117	0.00116	CcSEcCtD
Dalfampridine—Chest pain—Methotrexate—multiple sclerosis	0.000116	0.00115	CcSEcCtD
Dalfampridine—KCNQ5—Neuronal System—BCHE—multiple sclerosis	0.000116	0.000824	CbGpPWpGaD
Dalfampridine—KCNQ4—Neuronal System—BCHE—multiple sclerosis	0.000116	0.000824	CbGpPWpGaD
Dalfampridine—Rash—Prednisolone—multiple sclerosis	0.000115	0.00114	CcSEcCtD
Dalfampridine—Dermatitis—Prednisolone—multiple sclerosis	0.000115	0.00114	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000115	0.00114	CcSEcCtD
Dalfampridine—Headache—Prednisolone—multiple sclerosis	0.000115	0.00114	CcSEcCtD
Dalfampridine—Constipation—Prednisone—multiple sclerosis	0.000114	0.00113	CcSEcCtD
Dalfampridine—Confusional state—Methotrexate—multiple sclerosis	0.000112	0.00111	CcSEcCtD
Dalfampridine—Dizziness—Triamcinolone—multiple sclerosis	0.000111	0.0011	CcSEcCtD
Dalfampridine—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000111	0.0011	CcSEcCtD
Dalfampridine—Dizziness—Methylprednisolone—multiple sclerosis	0.000111	0.0011	CcSEcCtD
Dalfampridine—KCNH2—Neuronal System—KCNA3—multiple sclerosis	0.000111	0.00079	CbGpPWpGaD
Dalfampridine—CYP2E1—medulla oblongata—multiple sclerosis	0.000111	0.00104	CbGeAlD
Dalfampridine—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000111	0.000788	CbGpPWpGaD
Dalfampridine—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000111	0.000788	CbGpPWpGaD
Dalfampridine—Infection—Methotrexate—multiple sclerosis	0.00011	0.00109	CcSEcCtD
Dalfampridine—Feeling abnormal—Prednisone—multiple sclerosis	0.00011	0.00109	CcSEcCtD
Dalfampridine—Asthenia—Betamethasone—multiple sclerosis	0.00011	0.00109	CcSEcCtD
Dalfampridine—Asthenia—Dexamethasone—multiple sclerosis	0.00011	0.00109	CcSEcCtD
Dalfampridine—CYP2E1—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000109	0.000778	CbGpPWpGaD
Dalfampridine—CYP2E1—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000109	0.000778	CbGpPWpGaD
Dalfampridine—Nervous system disorder—Methotrexate—multiple sclerosis	0.000109	0.00108	CcSEcCtD
Dalfampridine—Nausea—Prednisolone—multiple sclerosis	0.000109	0.00108	CcSEcCtD
Dalfampridine—Skin disorder—Methotrexate—multiple sclerosis	0.000108	0.00107	CcSEcCtD
Dalfampridine—KCNH2—nervous system—multiple sclerosis	0.000108	0.00101	CbGeAlD
Dalfampridine—Vomiting—Triamcinolone—multiple sclerosis	0.000107	0.00106	CcSEcCtD
Dalfampridine—Vomiting—Methylprednisolone—multiple sclerosis	0.000107	0.00106	CcSEcCtD
Dalfampridine—Rash—Triamcinolone—multiple sclerosis	0.000106	0.00105	CcSEcCtD
Dalfampridine—Dermatitis—Triamcinolone—multiple sclerosis	0.000106	0.00105	CcSEcCtD
Dalfampridine—Rash—Methylprednisolone—multiple sclerosis	0.000106	0.00105	CcSEcCtD
Dalfampridine—Dermatitis—Methylprednisolone—multiple sclerosis	0.000106	0.00105	CcSEcCtD
Dalfampridine—Urticaria—Prednisone—multiple sclerosis	0.000106	0.00105	CcSEcCtD
Dalfampridine—Headache—Triamcinolone—multiple sclerosis	0.000105	0.00104	CcSEcCtD
Dalfampridine—Headache—Methylprednisolone—multiple sclerosis	0.000105	0.00104	CcSEcCtD
Dalfampridine—KCNH2—central nervous system—multiple sclerosis	0.000104	0.000976	CbGeAlD
Dalfampridine—Hypotension—Methotrexate—multiple sclerosis	0.000104	0.00103	CcSEcCtD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	0.000102	0.00073	CbGpPWpGaD
Dalfampridine—KCNH2—cerebellum—multiple sclerosis	0.000102	0.000954	CbGeAlD
Dalfampridine—Dizziness—Betamethasone—multiple sclerosis	0.000101	0.001	CcSEcCtD
Dalfampridine—Dizziness—Dexamethasone—multiple sclerosis	0.000101	0.001	CcSEcCtD
Dalfampridine—Insomnia—Methotrexate—multiple sclerosis	0.000101	0.000995	CcSEcCtD
Dalfampridine—Nausea—Triamcinolone—multiple sclerosis	9.99e-05	0.00099	CcSEcCtD
Dalfampridine—Paraesthesia—Methotrexate—multiple sclerosis	9.98e-05	0.000988	CcSEcCtD
Dalfampridine—Nausea—Methylprednisolone—multiple sclerosis	9.97e-05	0.000988	CcSEcCtD
Dalfampridine—Dyspnoea—Methotrexate—multiple sclerosis	9.91e-05	0.000981	CcSEcCtD
Dalfampridine—CYP2E1—spinal cord—multiple sclerosis	9.86e-05	0.000927	CbGeAlD
Dalfampridine—Hypersensitivity—Prednisone—multiple sclerosis	9.8e-05	0.00097	CcSEcCtD
Dalfampridine—Dyspepsia—Methotrexate—multiple sclerosis	9.78e-05	0.000969	CcSEcCtD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—IL10—multiple sclerosis	9.77e-05	0.000697	CbGpPWpGaD
Dalfampridine—Vomiting—Betamethasone—multiple sclerosis	9.71e-05	0.000962	CcSEcCtD
Dalfampridine—Vomiting—Dexamethasone—multiple sclerosis	9.71e-05	0.000962	CcSEcCtD
Dalfampridine—KCNS3—Neuronal System—BCHE—multiple sclerosis	9.68e-05	0.000691	CbGpPWpGaD
Dalfampridine—KCNG2—Neuronal System—BCHE—multiple sclerosis	9.68e-05	0.000691	CbGpPWpGaD
Dalfampridine—KCNC2—Neuronal System—BCHE—multiple sclerosis	9.68e-05	0.000691	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—C4A—multiple sclerosis	9.66e-05	0.000689	CbGpPWpGaD
Dalfampridine—Rash—Betamethasone—multiple sclerosis	9.63e-05	0.000954	CcSEcCtD
Dalfampridine—Rash—Dexamethasone—multiple sclerosis	9.63e-05	0.000954	CcSEcCtD
Dalfampridine—Dermatitis—Dexamethasone—multiple sclerosis	9.62e-05	0.000953	CcSEcCtD
Dalfampridine—Dermatitis—Betamethasone—multiple sclerosis	9.62e-05	0.000953	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Methotrexate—multiple sclerosis	9.59e-05	0.00095	CcSEcCtD
Dalfampridine—Headache—Betamethasone—multiple sclerosis	9.56e-05	0.000947	CcSEcCtD
Dalfampridine—Headache—Dexamethasone—multiple sclerosis	9.56e-05	0.000947	CcSEcCtD
Dalfampridine—Asthenia—Prednisone—multiple sclerosis	9.54e-05	0.000945	CcSEcCtD
Dalfampridine—KCND3—Neuronal System—BCHE—multiple sclerosis	9.42e-05	0.000672	CbGpPWpGaD
Dalfampridine—KCNB1—Neuronal System—BCHE—multiple sclerosis	9.18e-05	0.000655	CbGpPWpGaD
Dalfampridine—Feeling abnormal—Methotrexate—multiple sclerosis	9.16e-05	0.000907	CcSEcCtD
Dalfampridine—Nausea—Dexamethasone—multiple sclerosis	9.07e-05	0.000898	CcSEcCtD
Dalfampridine—Nausea—Betamethasone—multiple sclerosis	9.07e-05	0.000898	CcSEcCtD
Dalfampridine—CYP2E1—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	8.96e-05	0.000639	CbGpPWpGaD
Dalfampridine—CYP2E1—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	8.96e-05	0.000639	CbGpPWpGaD
Dalfampridine—Urticaria—Methotrexate—multiple sclerosis	8.83e-05	0.000874	CcSEcCtD
Dalfampridine—Dizziness—Prednisone—multiple sclerosis	8.79e-05	0.000871	CcSEcCtD
Dalfampridine—Vomiting—Prednisone—multiple sclerosis	8.45e-05	0.000837	CcSEcCtD
Dalfampridine—KCNQ1—Neuronal System—BCHE—multiple sclerosis	8.4e-05	0.000599	CbGpPWpGaD
Dalfampridine—KCND2—Neuronal System—BCHE—multiple sclerosis	8.4e-05	0.000599	CbGpPWpGaD
Dalfampridine—Rash—Prednisone—multiple sclerosis	8.38e-05	0.00083	CcSEcCtD
Dalfampridine—Dermatitis—Prednisone—multiple sclerosis	8.38e-05	0.00083	CcSEcCtD
Dalfampridine—Headache—Prednisone—multiple sclerosis	8.33e-05	0.000825	CcSEcCtD
Dalfampridine—CYP2E1—nervous system—multiple sclerosis	8.31e-05	0.000781	CbGeAlD
Dalfampridine—KCNH2—brain—multiple sclerosis	8.25e-05	0.000775	CbGeAlD
Dalfampridine—KCNH6—Neuronal System—BCHE—multiple sclerosis	8.23e-05	0.000587	CbGpPWpGaD
Dalfampridine—Hypersensitivity—Methotrexate—multiple sclerosis	8.19e-05	0.000811	CcSEcCtD
Dalfampridine—CYP2E1—central nervous system—multiple sclerosis	8e-05	0.000752	CbGeAlD
Dalfampridine—Asthenia—Methotrexate—multiple sclerosis	7.97e-05	0.00079	CcSEcCtD
Dalfampridine—KCNG2—Metabolism—SRM—multiple sclerosis	7.95e-05	0.000567	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—SRM—multiple sclerosis	7.95e-05	0.000567	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—SRM—multiple sclerosis	7.95e-05	0.000567	CbGpPWpGaD
Dalfampridine—Nausea—Prednisone—multiple sclerosis	7.9e-05	0.000782	CcSEcCtD
Dalfampridine—CYP2E1—cerebellum—multiple sclerosis	7.82e-05	0.000735	CbGeAlD
Dalfampridine—KCNB1—Metabolism—SRM—multiple sclerosis	7.54e-05	0.000538	CbGpPWpGaD
Dalfampridine—KCNA1—Neuronal System—BCHE—multiple sclerosis	7.45e-05	0.000531	CbGpPWpGaD
Dalfampridine—Dizziness—Methotrexate—multiple sclerosis	7.35e-05	0.000728	CcSEcCtD
Dalfampridine—KCNH7—Neuronal System—BCHE—multiple sclerosis	7.34e-05	0.000523	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—AQP4—multiple sclerosis	7.32e-05	0.000522	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—PRNP—multiple sclerosis	7.3e-05	0.000521	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—PRNP—multiple sclerosis	7.3e-05	0.000521	CbGpPWpGaD
Dalfampridine—KCND2—Circadian rythm related genes—FAS—multiple sclerosis	7.15e-05	0.00051	CbGpPWpGaD
Dalfampridine—Vomiting—Methotrexate—multiple sclerosis	7.07e-05	0.0007	CcSEcCtD
Dalfampridine—Rash—Methotrexate—multiple sclerosis	7.01e-05	0.000694	CcSEcCtD
Dalfampridine—Dermatitis—Methotrexate—multiple sclerosis	7e-05	0.000693	CcSEcCtD
Dalfampridine—Headache—Methotrexate—multiple sclerosis	6.96e-05	0.00069	CcSEcCtD
Dalfampridine—KCNA3—BDNF signaling pathway—STAT3—multiple sclerosis	6.61e-05	0.000471	CbGpPWpGaD
Dalfampridine—Nausea—Methotrexate—multiple sclerosis	6.6e-05	0.000654	CcSEcCtD
Dalfampridine—CYP2E1—brain—multiple sclerosis	6.35e-05	0.000597	CbGeAlD
Dalfampridine—KCNH7—Circadian rythm related genes—FAS—multiple sclerosis	6.25e-05	0.000446	CbGpPWpGaD
Dalfampridine—KCNQ2—Neuronal System—BCHE—multiple sclerosis	6.24e-05	0.000445	CbGpPWpGaD
Dalfampridine—KCNQ3—Neuronal System—BCHE—multiple sclerosis	6.24e-05	0.000445	CbGpPWpGaD
Dalfampridine—KCNA3—BDNF signaling pathway—MAPK1—multiple sclerosis	6.01e-05	0.000428	CbGpPWpGaD
Dalfampridine—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	5.7e-05	0.000406	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—PTPRC—multiple sclerosis	5.68e-05	0.000405	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—PTPRC—multiple sclerosis	5.68e-05	0.000405	CbGpPWpGaD
Dalfampridine—KCNH2—Hematopoietic Stem Cell Differentiation—IL1B—multiple sclerosis	5.64e-05	0.000402	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CYP27B1—multiple sclerosis	5.6e-05	0.000399	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CYP27B1—multiple sclerosis	5.6e-05	0.000399	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CYP24A1—multiple sclerosis	5.6e-05	0.000399	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CYP27B1—multiple sclerosis	5.6e-05	0.000399	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CYP24A1—multiple sclerosis	5.6e-05	0.000399	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CYP24A1—multiple sclerosis	5.6e-05	0.000399	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CYP27B1—multiple sclerosis	5.31e-05	0.000379	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CYP24A1—multiple sclerosis	5.31e-05	0.000379	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—PRNP—multiple sclerosis	5.21e-05	0.000372	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—PRNP—multiple sclerosis	5.21e-05	0.000372	CbGpPWpGaD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	5.13e-05	0.000366	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—GPC5—multiple sclerosis	5.12e-05	0.000365	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—GPC5—multiple sclerosis	5.12e-05	0.000365	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—GPC5—multiple sclerosis	5.12e-05	0.000365	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—GPC5—multiple sclerosis	4.86e-05	0.000346	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—CYP27B1—multiple sclerosis	4.76e-05	0.000339	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—CYP24A1—multiple sclerosis	4.76e-05	0.000339	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—CYP24A1—multiple sclerosis	4.69e-05	0.000335	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—CYP27B1—multiple sclerosis	4.69e-05	0.000335	CbGpPWpGaD
Dalfampridine—KCNQ2—L1CAM interactions—MAPK1—multiple sclerosis	4.28e-05	0.000305	CbGpPWpGaD
Dalfampridine—KCNQ3—L1CAM interactions—MAPK1—multiple sclerosis	4.28e-05	0.000305	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—RRM1—multiple sclerosis	4.25e-05	0.000303	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—RRM1—multiple sclerosis	4.25e-05	0.000303	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—RRM1—multiple sclerosis	4.25e-05	0.000303	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—PTPRC—multiple sclerosis	4.05e-05	0.000289	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—PTPRC—multiple sclerosis	4.05e-05	0.000289	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—RRM1—multiple sclerosis	4.02e-05	0.000287	CbGpPWpGaD
Dalfampridine—KCNC4—Neuronal System—MAPK1—multiple sclerosis	3.97e-05	0.000283	CbGpPWpGaD
Dalfampridine—KCNH4—Neuronal System—MAPK1—multiple sclerosis	3.97e-05	0.000283	CbGpPWpGaD
Dalfampridine—KCNH5—Neuronal System—MAPK1—multiple sclerosis	3.97e-05	0.000283	CbGpPWpGaD
Dalfampridine—KCNG1—Neuronal System—MAPK1—multiple sclerosis	3.97e-05	0.000283	CbGpPWpGaD
Dalfampridine—KCND1—Neuronal System—MAPK1—multiple sclerosis	3.97e-05	0.000283	CbGpPWpGaD
Dalfampridine—KCNH8—Neuronal System—MAPK1—multiple sclerosis	3.97e-05	0.000283	CbGpPWpGaD
Dalfampridine—KCNA5—Neuronal System—MAPK1—multiple sclerosis	3.97e-05	0.000283	CbGpPWpGaD
Dalfampridine—KCNG3—Neuronal System—MAPK1—multiple sclerosis	3.97e-05	0.000283	CbGpPWpGaD
Dalfampridine—KCNA4—Neuronal System—MAPK1—multiple sclerosis	3.97e-05	0.000283	CbGpPWpGaD
Dalfampridine—KCNV1—Neuronal System—MAPK1—multiple sclerosis	3.97e-05	0.000283	CbGpPWpGaD
Dalfampridine—KCNA2—Neuronal System—MAPK1—multiple sclerosis	3.97e-05	0.000283	CbGpPWpGaD
Dalfampridine—KCNC3—Neuronal System—MAPK1—multiple sclerosis	3.97e-05	0.000283	CbGpPWpGaD
Dalfampridine—KCNS1—Neuronal System—MAPK1—multiple sclerosis	3.97e-05	0.000283	CbGpPWpGaD
Dalfampridine—KCNA10—Neuronal System—MAPK1—multiple sclerosis	3.97e-05	0.000283	CbGpPWpGaD
Dalfampridine—KCNS2—Neuronal System—MAPK1—multiple sclerosis	3.97e-05	0.000283	CbGpPWpGaD
Dalfampridine—KCNH1—Neuronal System—MAPK1—multiple sclerosis	3.97e-05	0.000283	CbGpPWpGaD
Dalfampridine—KCNC1—Neuronal System—MAPK1—multiple sclerosis	3.97e-05	0.000283	CbGpPWpGaD
Dalfampridine—KCNB2—Neuronal System—MAPK1—multiple sclerosis	3.97e-05	0.000283	CbGpPWpGaD
Dalfampridine—KCNA7—Neuronal System—MAPK1—multiple sclerosis	3.97e-05	0.000283	CbGpPWpGaD
Dalfampridine—KCNG4—Neuronal System—MAPK1—multiple sclerosis	3.97e-05	0.000283	CbGpPWpGaD
Dalfampridine—KCNH3—Neuronal System—MAPK1—multiple sclerosis	3.97e-05	0.000283	CbGpPWpGaD
Dalfampridine—KCNA6—Neuronal System—MAPK1—multiple sclerosis	3.97e-05	0.000283	CbGpPWpGaD
Dalfampridine—KCNF1—Neuronal System—MAPK1—multiple sclerosis	3.97e-05	0.000283	CbGpPWpGaD
Dalfampridine—KCNV2—Neuronal System—MAPK1—multiple sclerosis	3.97e-05	0.000283	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	3.79e-05	0.00027	CbGpPWpGaD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—TNF—multiple sclerosis	3.72e-05	0.000265	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—IL10—multiple sclerosis	3.62e-05	0.000258	CbGpPWpGaD
Dalfampridine—KCNA3—Neuronal System—MAPK1—multiple sclerosis	3.54e-05	0.000252	CbGpPWpGaD
Dalfampridine—KCNQ5—Neuronal System—MAPK1—multiple sclerosis	3.38e-05	0.000241	CbGpPWpGaD
Dalfampridine—KCNQ4—Neuronal System—MAPK1—multiple sclerosis	3.38e-05	0.000241	CbGpPWpGaD
Dalfampridine—KCNH2—Hematopoietic Stem Cell Differentiation—IL6—multiple sclerosis	3.3e-05	0.000235	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—BCHE—multiple sclerosis	3.11e-05	0.000222	CbGpPWpGaD
Dalfampridine—KCNQ1—SIDS Susceptibility Pathways—IL6—multiple sclerosis	3e-05	0.000214	CbGpPWpGaD
Dalfampridine—KCNC2—Neuronal System—MAPK1—multiple sclerosis	2.83e-05	0.000202	CbGpPWpGaD
Dalfampridine—KCNS3—Neuronal System—MAPK1—multiple sclerosis	2.83e-05	0.000202	CbGpPWpGaD
Dalfampridine—KCNG2—Neuronal System—MAPK1—multiple sclerosis	2.83e-05	0.000202	CbGpPWpGaD
Dalfampridine—KCND3—Neuronal System—MAPK1—multiple sclerosis	2.75e-05	0.000196	CbGpPWpGaD
Dalfampridine—KCNB1—Neuronal System—MAPK1—multiple sclerosis	2.68e-05	0.000191	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—TYK2—multiple sclerosis	2.54e-05	0.000181	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—TYK2—multiple sclerosis	2.54e-05	0.000181	CbGpPWpGaD
Dalfampridine—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	2.49e-05	0.000177	CbGpPWpGaD
Dalfampridine—KCND2—Neuronal System—MAPK1—multiple sclerosis	2.45e-05	0.000175	CbGpPWpGaD
Dalfampridine—KCNQ1—Neuronal System—MAPK1—multiple sclerosis	2.45e-05	0.000175	CbGpPWpGaD
Dalfampridine—KCND2—Circadian rythm related genes—IL6—multiple sclerosis	2.45e-05	0.000175	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—BCHE—multiple sclerosis	2.44e-05	0.000174	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—BCHE—multiple sclerosis	2.44e-05	0.000174	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—BCHE—multiple sclerosis	2.44e-05	0.000174	CbGpPWpGaD
Dalfampridine—KCNH6—Neuronal System—MAPK1—multiple sclerosis	2.41e-05	0.000172	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—BCHE—multiple sclerosis	2.31e-05	0.000165	CbGpPWpGaD
Dalfampridine—KCNA1—Neuronal System—MAPK1—multiple sclerosis	2.18e-05	0.000155	CbGpPWpGaD
Dalfampridine—KCNH7—Neuronal System—MAPK1—multiple sclerosis	2.14e-05	0.000153	CbGpPWpGaD
Dalfampridine—KCNH7—Circadian rythm related genes—IL6—multiple sclerosis	2.14e-05	0.000153	CbGpPWpGaD
Dalfampridine—CYP2E1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	2.02e-05	0.000144	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—MMP9—multiple sclerosis	2e-05	0.000143	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—MMP9—multiple sclerosis	2e-05	0.000143	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	1.9e-05	0.000135	CbGpPWpGaD
Dalfampridine—CYP2E1—Vitamin A and Carotenoid Metabolism—MAPK1—multiple sclerosis	1.84e-05	0.000131	CbGpPWpGaD
Dalfampridine—KCNQ2—Neuronal System—MAPK1—multiple sclerosis	1.82e-05	0.00013	CbGpPWpGaD
Dalfampridine—KCNQ3—Neuronal System—MAPK1—multiple sclerosis	1.82e-05	0.00013	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—TYK2—multiple sclerosis	1.81e-05	0.000129	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—TYK2—multiple sclerosis	1.81e-05	0.000129	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—MAPK1—multiple sclerosis	1.62e-05	0.000115	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—MAPK1—multiple sclerosis	1.62e-05	0.000115	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—APOE—multiple sclerosis	1.47e-05	0.000105	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—APOE—multiple sclerosis	1.47e-05	0.000105	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—APOE—multiple sclerosis	1.47e-05	0.000105	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—MMP9—multiple sclerosis	1.43e-05	0.000102	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—MMP9—multiple sclerosis	1.43e-05	0.000102	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—APOE—multiple sclerosis	1.39e-05	9.92e-05	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—TNF—multiple sclerosis	1.38e-05	9.82e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—STAT3—multiple sclerosis	1.27e-05	9.06e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—STAT3—multiple sclerosis	1.27e-05	9.06e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—POMC—multiple sclerosis	1.26e-05	8.99e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—POMC—multiple sclerosis	1.26e-05	8.99e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—POMC—multiple sclerosis	1.26e-05	8.99e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—IL6—multiple sclerosis	1.24e-05	8.87e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—IL6—multiple sclerosis	1.24e-05	8.87e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—POMC—multiple sclerosis	1.19e-05	8.52e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—TGFB1—multiple sclerosis	1.18e-05	8.4e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—TGFB1—multiple sclerosis	1.18e-05	8.4e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—SRM—multiple sclerosis	1.16e-05	8.24e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—MAPK1—multiple sclerosis	1.15e-05	8.23e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—MAPK1—multiple sclerosis	1.15e-05	8.23e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—ALB—multiple sclerosis	1.15e-05	8.19e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—ALB—multiple sclerosis	1.15e-05	8.19e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—ALB—multiple sclerosis	1.15e-05	8.19e-05	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—IL6—multiple sclerosis	1.11e-05	7.92e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—TNF—multiple sclerosis	1.1e-05	7.84e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—TNF—multiple sclerosis	1.1e-05	7.84e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—ALB—multiple sclerosis	1.09e-05	7.77e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—POMC—multiple sclerosis	1.07e-05	7.63e-05	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—MAPK1—multiple sclerosis	9.08e-06	6.48e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—IL6—multiple sclerosis	8.87e-06	6.33e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—IL6—multiple sclerosis	8.87e-06	6.33e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CYP24A1—multiple sclerosis	8.14e-06	5.8e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CYP27B1—multiple sclerosis	8.14e-06	5.8e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GPC5—multiple sclerosis	7.44e-06	5.31e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—RRM1—multiple sclerosis	6.17e-06	4.4e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—BCHE—multiple sclerosis	3.54e-06	2.53e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—APOE—multiple sclerosis	2.13e-06	1.52e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—POMC—multiple sclerosis	1.83e-06	1.31e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ALB—multiple sclerosis	1.67e-06	1.19e-05	CbGpPWpGaD
